DGAP-News: Alphaform AG: Alphaform presents final figures for the 2014 financial year


DGAP-News: Alphaform AG / Key word(s): Final Results
Alphaform AG: Alphaform presents final figures for the 2014 financial
year

30.03.2015 / 11:33

---------------------------------------------------------------------

Press Release

Alphaform presents final figures for the 2014 financial year 

  - Revenue rises to EUR29.1 million in 2014

  - EBITDA improves to EUR-1.3 million

  - For 2015, Alphaform anticipates another double-digit increase in
    revenue and a significant improvement in earnings

Feldkirchen, 30 March 2015. Alphaform AG, Europe's leading industrial 3D
printing service provider, published its 2014 annual report today. It does
not contain any significant changes in comparison to the preliminary
figures published on 26 February 2015.

According to the annual report, revenue in the last financial year rose by
12.4% to EUR29.1 million. EBITDA improved by EUR2.2 million to EUR-1.3
million and the consolidated net loss improved by EUR3.0 million to EUR-3.2
million.

The year 2014 was influenced by extensive restructuring as part of the
Alphaform Excellence programme. This programme, launched in the first
quarter of 2014, is based on five pillars: in addition to improving
processes and structures in the three business segments, it also includes
strengthening sales and the corporate culture. For four of the five
pillars, the programme took effect as planned during 2014 and made a key
contribution to the significant improvement in the earnings situation in
two of the three business segments. For the third business segment,
Additive Manufacturing Plastic at the Feldkirchen location, the Management
Board additionally established an 11-point plan in autumn 2014 in light of
continuing challenges. This plan will now be implemented in 2015 as
systematically as the Excellence programme itself.

Alphaform anticipates further improvement in revenue and earnings in 2015

For 2015 as a whole, Alphaform plans a double-digit increase in revenue and
another significant improvement in earnings. After investments totalling
EUR3.0 million in 2014, the company will make substantial investments in
machinery and in ongoing strengthening of sales in 2015 as well. Financing
is ensured by the fact that cash and cash equivalents doubled year-on-year
to EUR2.4 million as at 31 December 2014, as well as by the most recent
capital increase on 16 March 2015 involving new investors with a long-term
focus.

At the same time, Alphaform is working on the demanding process of
obtaining further certification in order to establish itself as a series
manufacturer for promising sectors such as the aerospace industry.
Alphaform is already certified for medical technology and expects to
receive an order for 3D printing of medical technology implants for the
first time in the current year. Alphaform CEO Dr Hanns-Dieter Aberle
explains: "We are entering a new era. More and more applications for 3D
printing are emerging in more and more sectors - and Alphaform is among the
pioneers." Alphaform therefore intends to participate at an above-average
rate in the continued double-digit market growth in the years ahead that is
forecast by market researchers. In this context, the company is also
focussing on linking state-of-the-art manufacturing methods with digital
approaches. CEO Aberle comments: "Alphaform is already living in the age of
Industry 4.0. We intend to build on this lead in 2015 and beyond."

The full annual report is available for download at
http://www.alphaform.de/de/investor-relations/news/finanzberichte/.

<pre>

Key figures in EUR million          2014            2013            Change
Revenue                             29.1            25.9            +12.4%
EBITDA                              -1.3            -3.5            -62.8%
Operating result                    -2.6            -5.8            -55.2%
Consolidated net profit/loss        -3.2            -6.2            -48.4%
Earnings per share                  EUR-0.42        EUR-1.16        -63.8%
Equity*                             9.6             6.6             +45.5%
Liquidity*                          2.4             1.2             +100%
Total assets*                       20.0            15.8            +26.6%
Employees*                          249             227             +9.7%


</pre>

* as at 31 December

About Alphaform 

Founded in 1996 and headquartered in Feldkirchen near Munich, Alphaform AG
is a leading European handler for the renovation of industrial development
and production with innovative 3D printing and rapid technologies. As a
service provider, Alphaform guides its clients from product development
through to product manufacture; it assists them in introducing and
utilising innovations and delivers expertise, engineering knowledge,
prototypes, individual parts, small-scale series, series and project
management.

Among others, Alphaform today serves the premium manufacturers of the
automotive industry, mechanical, plant and automotive engineering, the
aerospace industry, tool making and medical technology. Its particular
areas of expertise include complex assembly, lightweight construction and
orthopaedic implants and instruments. It has subsidiaries in Germany,
Finland, Sweden and the UK. Alphaform's shares are listed in the Prime
Standard segment of the Frankfurt stock exchange (code: ATF; securities
code number (WKN): 548 795).

Contact: 
Dr. Hanns-Dieter Aberle, CEO Thomas Kresser, CFO
Alphaform AG Alphaform AG
Kapellenstraße 10 Kapellenstraße 10
85622 Feldkirchen 85622 Feldkirchen
Tel.: +49 89 905002 35 Tel.: +49 89 905002 35
Fax: +49 89 905002 1035 Fax: +49 89 905002 1035
e-mail: hdaberle@alphaform.de  e-mail: tkresser@alphaform.de
Internet: www.alphaform.de Internet: www.alphaform.de

Disclaimer

This press release/ad-hoc disclosure is not an offer document and does not
constitute an offer of shares of Alphaform AG ("Company") nor an invitation
to an offer to buy or subscribe for shares or securities of the Company but
is provided for information only. This press release/ad-hoc disclosure may
contain forward-looking statements that are subject to risks and
uncertainties, including those pertaining to the anticipated benefits to be
realized from the proposals described herein. Forward-looking statements
may include, in particular, statements about future events, future
financial performance, plans, strategies, expectations, prospects,
competitive environment, regulation and supply and demand. The Company has
based these forward-looking statements on its views and assumptions with
respect to future events and financial performance. Actual financial
performance could differ materially from that projected in the
forward-looking statements due to the inherent uncertainty of estimates,
forecasts and projections, and financial performance may be better or worse
than anticipated. Given these uncertainties, persons should not put undue
reliance on any forward-looking statements. The information contained in
this presentation is subject to change without notice and the Company does
not undertake any duty to update the forward-looking statements, and the
estimates and assumptions associated with them, except to the extent
required by applicable laws and regulations.

Important notice to persons in the United States of America

All information in this press release/ad-hoc disclosure is being made
available in the United States of America only to persons believed by the
Company to be capable of understanding and evaluating the risks of a
transaction. No shares or other securities of the Company have been
registered or otherwise qualify for a public sale or resale under federal
or state laws in the United States of America. Each recipient of
information doing business in or organized under any federal or state laws
in the United States of America or in areas subject to its jurisdiction
represents that it is an "accredited investor" as defined by Rule 501 or
Regulation D under the Securities Act of 1993 ("the Act") and acknowledges
that none of the shares in the Company will be registered under the Act and
cannot be resold in the absence of such registration or the availability of
an exemption there from. The shares in the Company have not been approved
or disapproved by the United States Securities and Exchange Commission, any
state securities commission or other regulatory authority, nor have any of
these authorities passed judgment upon or endorsed the merits of an
investment in the shares of the Company or the accuracy or adequacy of this
presentation. Any representation to the contrary is a criminal offence.

Important notice to persons in the United Kingdom

All information in this press release/ad-hoc disclosure is being made
available to the recipients on the basis that they are persons covered by
Article 11(3) of the Financial Services Act 1986 (Investment
Advertisements) (Exemptions) Order 1996. By accepting this document the
recipient warrants and represents that he or it is such a person.



---------------------------------------------------------------------

30.03.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                                    
Company:     Alphaform AG                                               
             Kapellenstraße 10                                          
             85622 Feldkirchen                                          
             Germany                                                    
Phone:       +49 (0)89 905002 - 0                                       
Fax:         +49 (0)89 905002 - 90                                      
E-mail:      ir@alphaform.de                                            
Internet:    www.alphaform.de                                           
ISIN:        DE0005487953                                               
WKN:         548795                                                     
Listed:      Regulated Market in Frankfurt (Prime Standard); Regulated  
             Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,  
             Stuttgart                                                  
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
339161 30.03.2015